349 related articles for article (PubMed ID: 26671581)
1. Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion.
Pages M; Lacroix L; Tauziede-Espariat A; Castel D; Daudigeos-Dubus E; Ridola V; Gilles S; Fina F; Andreiuolo F; Polivka M; Lechapt-Zalcman E; Puget S; Boddaert N; Liu XQ; Bridge JA; Grill J; Chretien F; Varlet P
Acta Neuropathol Commun; 2015 Dec; 3():85. PubMed ID: 26671581
[TBL] [Abstract][Full Text] [Related]
2. SLC44A1-PRKCA fusion in papillary and rosette-forming glioneuronal tumors.
Nagaishi M; Nobusawa S; Matsumura N; Kono F; Ishiuchi S; Abe T; Ebato M; Wang Y; Hyodo A; Yokoo H; Nakazato Y
J Clin Neurosci; 2016 Jan; 23():73-75. PubMed ID: 26260115
[TBL] [Abstract][Full Text] [Related]
3. Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA.
Hou Y; Pinheiro J; Sahm F; Reuss DE; Schrimpf D; Stichel D; Casalini B; Koelsche C; Sievers P; Wefers AK; Reinhardt A; Ebrahimi A; Fernández-Klett F; Pusch S; Meier J; Schweizer L; Paulus W; Prinz M; Hartmann C; Plate KH; Reifenberger G; Pietsch T; Varlet P; Pagès M; Schüller U; Scheie D; de Stricker K; Frank S; Hench J; Pollo B; Brandner S; Unterberg A; Pfister SM; Jones DTW; Korshunov A; Wick W; Capper D; Blümcke I; von Deimling A; Bertero L
Acta Neuropathol; 2019 May; 137(5):837-846. PubMed ID: 30759284
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel, recurrent SLC44A1-PRKCA fusion in papillary glioneuronal tumor.
Bridge JA; Liu XQ; Sumegi J; Nelson M; Reyes C; Bruch LA; Rosenblum M; Puccioni MJ; Bowdino BS; McComb RD
Brain Pathol; 2013 Mar; 23(2):121-8. PubMed ID: 22725730
[TBL] [Abstract][Full Text] [Related]
5. EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity.
Siegfried A; Rousseau A; Maurage CA; Pericart S; Nicaise Y; Escudie F; Grand D; Delrieu A; Gomez-Brouchet A; Le Guellec S; Franchet C; Boetto S; Vinchon M; Sol JC; Roux FE; Rigau V; Bertozzi AI; Jones DTW; Figarella-Branger D; Uro-Coste E
Brain Pathol; 2019 Jan; 29(1):53-62. PubMed ID: 29679497
[TBL] [Abstract][Full Text] [Related]
6. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].
Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118
[No Abstract] [Full Text] [Related]
7. An individual patient data meta-analysis on characteristics and outcome of patients with papillary glioneuronal tumor, rosette glioneuronal tumor with neuropil-like islands and rosette forming glioneuronal tumor of the fourth ventricle.
Schlamann A; von Bueren AO; Hagel C; Zwiener I; Seidel C; Kortmann RD; Müller K
PLoS One; 2014; 9(7):e101211. PubMed ID: 24991807
[TBL] [Abstract][Full Text] [Related]
8. Low-grade developmental and epilepsy associated brain tumors: a critical update 2020.
Slegers RJ; Blumcke I
Acta Neuropathol Commun; 2020 Mar; 8(1):27. PubMed ID: 32151273
[TBL] [Abstract][Full Text] [Related]
9. FGFR1 N546K mutation in a case of papillary glioneuronal tumor (PGNT).
Gessi M; Abdel Moneim Y; Hammes J; Waha A; Pietsch T
Acta Neuropathol; 2014; 127(6):935-6. PubMed ID: 24777483
[No Abstract] [Full Text] [Related]
10. Papillary glioneuronal tumor present in a patient with encephalocraniocutaneous lipomatosis: case report.
Phi JH; Park SH; Chae JH; Wang KC; Cho BK; Kim SK
Neurosurgery; 2010 Oct; 67(4):E1165-9. PubMed ID: 20881536
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas.
Kumar A; Pathak P; Purkait S; Faruq M; Jha P; Mallick S; Suri V; Sharma MC; Suri A; Sarkar C
Cancer Genet; 2015 Mar; 208(3):91-5. PubMed ID: 25794445
[TBL] [Abstract][Full Text] [Related]
12. Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: the implication of a common progenitor cell?
Matsumura N; Yokoo H; Mao Y; Yin W; Nakazato Y
Neuropathology; 2013 Jun; 33(3):246-55. PubMed ID: 23025580
[TBL] [Abstract][Full Text] [Related]
13. An epilepsy-associated glioneuronal tumor with mixed morphology harboring FGFR1 mutation.
Yamada S; Nobusawa S; Yamazaki T; Teranishi T; Watanabe S; Murayama K; Ohba S; Okabe A; Sakurai K; Urano M; Tsukamoto T; Yokoo H; Hirose Y; Abe M
Pathol Int; 2019 Jun; 69(6):372-377. PubMed ID: 31218776
[TBL] [Abstract][Full Text] [Related]
14. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
[TBL] [Abstract][Full Text] [Related]
16. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.
Fina F; Barets D; Colin C; Bouvier C; Padovani L; Nanni-Metellus I; Ouafik L; Scavarda D; Korshunov A; Jones DT; Figarella-Branger D
Oncotarget; 2017 Jan; 8(2):2104-2113. PubMed ID: 27791984
[TBL] [Abstract][Full Text] [Related]
17. Pediatric low-grade glioma in the era of molecular diagnostics.
Ryall S; Tabori U; Hawkins C
Acta Neuropathol Commun; 2020 Mar; 8(1):30. PubMed ID: 32164789
[TBL] [Abstract][Full Text] [Related]
18. Rosette-forming and papillary glioneuronal tumors - A clinicopathological and molecular analysis.
Singh V; Gupta K; Salunke P; Kumar S; Radotra BD; Vasishta RK
Clin Neuropathol; 2019; 38(4):180-188. PubMed ID: 30900987
[TBL] [Abstract][Full Text] [Related]
19. Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs).
Kakkar A; Majumdar A; Kumar A; Tripathi M; Pathak P; Sharma MC; Suri V; Tandon V; Chandra SP; Sarkar C
Epilepsy Res; 2016 Nov; 127():141-151. PubMed ID: 27599148
[TBL] [Abstract][Full Text] [Related]
20. FGFR1 mutations in Rosette-forming glioneuronal tumors of the fourth ventricle.
Gessi M; Moneim YA; Hammes J; Goschzik T; Scholz M; Denkhaus D; Waha A; Pietsch T
J Neuropathol Exp Neurol; 2014 Jun; 73(6):580-4. PubMed ID: 24806303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
